ORGANOVO HOLDINGS, INC. (32)
Browse by Contract Category
Contracts
-
Intercompany Agreement, dated December 28, 2020, by and among Organovo Holdings, Inc., Organovo, Inc. and Viscient Biosciences, Inc
(Filed With SEC on December 31, 2020)
-
Consulting Agreement, dated August 25, 2020, by and between Organovo and Danforth Advisors
(Filed With SEC on November 5, 2020)
-
Form of Release Agreement by Keith Murphy in favor of the Companys directors and officers
(Filed With SEC on July 15, 2020)
-
Cooperation Agreement, dated July 14, 2020, between the Company and Keith Murphy
(Filed With SEC on July 15, 2020)
-
First Amendment to Merger Agreement, dated January 26, 2020, by and among Organovo, Merger Sub and Tarveda
(Filed With SEC on January 29, 2020)
-
Lease, dated December 12, 2011, by and between BMR-134 Coolidge Avenue LLC and Tarveda Therapeutics, Inc. (formerly Blend Therapeutics, Inc.)
(Filed With SEC on December 23, 2019)
-
License Agreement, dated September 14, 2016, by and between Tarveda Therapeutics, Inc. and Madrigal Pharmaceuticals, Inc
(Filed With SEC on December 23, 2019)
-
Engagement Agreement, dated July 23, 2020, by and between Organovo and Optima Law Group of San Diego
(Filed With SEC on November 5, 2020)
-
Offer Letter, dated September 15, 2020, between the Company and Jeffrey N. Miner
(Filed With SEC on November 5, 2020)
-
Consulting Agreement, dated September 15, 2020, by and between Organovo and Multi Dimensional Bio Insight LLC
(Filed With SEC on November 5, 2020)
-
Form of Separation Agreement and Release with the Companys officers
(Filed With SEC on July 15, 2020)
-
Form of Separation and Mutual Release Agreement with the Companys directors
(Filed With SEC on July 15, 2020)
-
Description of Securities
(Filed With SEC on May 28, 2020)
-
Amendment to Organovo Holdings, Inc. Severance and Change in Control Plan, dated May 19, 2020
(Filed With SEC on May 20, 2020)
-
Form of Tarveda Therapeutics, Inc. Nondisclosure, Noncompetition and Assignment of Intellectual Property Agreement
(Filed With SEC on December 23, 2019)
-
Employment Agreement, dated July 27, 2018, by and between Tarveda Therapeutics, Inc. and Jeffrey Bloss
(Filed With SEC on December 23, 2019)
-
Employment Agreement, dated December 19, 2017, by and between Tarveda Therapeutics, Inc. and Brian Roberts
(Filed With SEC on December 23, 2019)
-
First Amendment to Lease, dated February 23, 2012, by and between BMR-134 Coolidge Avenue LLC and Tarveda Therapeutics, Inc. (formerly Blend Therapeutics, Inc.)
(Filed With SEC on December 23, 2019)
-
Fifth Amended and Restated Investor Rights Agreement, dated December 12, 2019, by and between Tarveda Therapeutics, Inc. and the stockholders party thereto
(Filed With SEC on December 23, 2019)
-
Loan and Security Agreement, dated March 29, 2019, among Oxford Finance LLC, the Lenders named therein, and Tarveda Therapeutics, Inc
(Filed With SEC on December 23, 2019)
-
Warrant to Purchase Stock issued by Tarveda Therapeutics, Inc. (formerly Blend Therapeutics, Inc.) to Comerica Bank, dated February 8, 2012
(Filed With SEC on December 23, 2019)
-
Warrant to Purchase Stock issued by Tarveda Therapeutics, Inc. (formerly Blend Therapeutics, Inc.) to Comerica Bank, dated November 19, 2013
(Filed With SEC on December 23, 2019)
-
Second Amendment to Lease, dated January 8, 2013, by and between BMR-134 Coolidge Avenue LLC and Tarveda Therapeutics, Inc. (formerly Blend Therapeutics, Inc.)
(Filed With SEC on December 23, 2019)
-
Third Amendment to Lease, dated April 19, 2016, by and between BMR-134 Coolidge Avenue LLC and Tarveda Therapeutics, Inc
(Filed With SEC on December 23, 2019)
-
Fourth Amendment to Lease, dated May 31, 2019, by and between BMR-134 Coolidge Avenue LLC and Tarveda Therapeutics, Inc
(Filed With SEC on December 23, 2019)
-
Tarveda Therapeutics, Inc. (formerly Blend Biosciences, Inc.) 2011 Stock Incentive Plan
(Filed With SEC on December 23, 2019)
-
Employment Agreement, dated March 2, 2015, by and between Tarveda Therapeutics, Inc. (formerly Blend Therapeutics, Inc.) and Andrew J. Fromkin
(Filed With SEC on December 23, 2019)
-
First Amendment to Employment Agreement, dated April 6, 2016, by and between Tarveda Therapeutics, Inc. and Andrew J. Fromkin
(Filed With SEC on December 23, 2019)
-
Form of Support Agreement, by and between Tarveda, Organovo and certain directors and officers of Organovo
(Filed With SEC on December 16, 2019)
-
Agreement and Plan of Merger and Reorganization, dated as of December 13, 2019, by and among Organovo, Merger Sub and Tarveda
(Filed With SEC on December 16, 2019)
-
Form of Lock-Up Agreement, by and among Tarveda, Organovo and certain directors and officers of Tarveda and Organovo
(Filed With SEC on December 16, 2019)
-
Form of Support Agreement, by and between Organovo, Tarveda and certain directors, officers and stockholders of Tarveda
(Filed With SEC on December 16, 2019)